Etrabamine

This classification denotes a dopamine antagonist with the molecular formula C8H12N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V55R69267Q, chemically known as 4,5,6,7-tetrahydro-6-(methylamino)benzothiazole but generally known as etrabamine, which bears US NIH Compound Identifier 68895. European Medicines Agency schedules Etrabamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07345MIG. The term ETRABAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). ETRABAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etrabamine under HS 29341000 and SITC 51579. As of Q4 2014, ETRABAMINE remains the US FDA Preferred Term for this commodity. Etrabamine bears US NLM identifiers UMLS ID C1880591 and NCI Concept Code C65601. SMILES: s1c2CC(NC)CCc2nc1.